This analysis showed a clear trend that CRC tissues with low KCTD9 expression had higher β-catenin expression while the converse was true for CRC tissues with high KCTD9 expression (Fig. 7F ).
← all excerpts
KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer.
1
—
—